Shanghai King-cell Biotechnology Co., Ltd. was established in Shanghai Jinshan Industrial Zone in April 19, 2017, is a commitment to innovation and safe vaccine R & D and production of bio pharmaceutical enterprises. The company formerly known as Zhongguancun is located in Beijing Beijing Purcell Forest Biotechnology Co. Ltd., after careful research for more than 6 years, Purified Hamster Kidney Cell Rabies Vaccine (CEF cell) clinical document will be completed; the new genotype with MMR vaccine development of inactivated rotavirus vaccine and respiratory syncytial virus vaccine.
The company in the Jinshan Industrial Zone covers an area of 80 acres, the first phase of construction including workshop, quality inspection building, animal laboratory, pilot plant and warehouse complex totaling 91 thousand square meters,
The company are in the spirit of manufacturing services for human health products, and strive to become honest, dignified, influential enterprises
To improve human health and benefit mankind
Honest, kind and ingenuity to create, for the benefit of mankind